| P50 | author | Navjeet Ahalawat | Q59676795 |
| | Angana Ray | Q85850391 |
| P2093 | author name string | Jagannath Mondal | |
| P2860 | cites work | Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease | Q22248091 |
| | A helix propensity scale based on experimental studies of peptides and proteins | Q24537262 |
| | Impact of apolipoprotein E on Alzheimer's disease | Q24567759 |
| | SPARTA+: a modest improvement in empirical NMR chemical shift prediction by means of an artificial neural network | Q24615699 |
| | CHARMM: the biomolecular simulation program | Q24658108 |
| | Markov state models of biomolecular conformational dynamics | Q26827934 |
| | Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E | Q27663468 |
| | Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions | Q27672294 |
| | Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms | Q27730887 |
| | Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features | Q27860675 |
| | Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease | Q28238269 |
| | The binding of apolipoprotein E to oligomers and fibrils of amyloid-β alters the kinetics of amyloid aggregation | Q30032680 |
| | A Collective Variable for the Efficient Exploration of Protein Beta-Sheet Structures: Application to SH3 and GB1. | Q30157140 |
| | Lipid binding-induced conformational changes in the N-terminal domain of human apolipoprotein E. | Q53940110 |
| | Self-association of Human Apolipoprotein E3 and E4 in the Presence and Absence of Phospholipid | Q61833223 |
| | Apolipoprotein E polymorphism and atherosclerosis | Q68126635 |
| | The locus for apolipoprotein E (apoE) is linked to the complement component C3 (C3) locus on chromosome 19 in man | Q70587571 |
| | CHARMM-GUI: a web-based graphical user interface for CHARMM | Q80900573 |
| | A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain-domain interactions | Q30402554 |
| | Statistically optimal analysis of samples from multiple equilibrium states | Q30438437 |
| | Molecular dynamics simulations of biomolecules: long-range electrostatic effects | Q33689931 |
| | Variants near CHRNA3/5 and APOE have age- and sex-related effects on human lifespan | Q33707773 |
| | Apolipoprotein E: From lipid transport to neurobiology | Q34497951 |
| | Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease | Q34662682 |
| | Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. | Q35076662 |
| | Hydrogen/deuterium exchange and electron-transfer dissociation mass spectrometry determine the interface and dynamics of apolipoprotein E oligomerization | Q35456689 |
| | ApoE4-specific Misfolded Intermediate Identified by Molecular Dynamics Simulations | Q35823248 |
| | PyEMMA 2: A Software Package for Estimation, Validation, and Analysis of Markov Models. | Q35843343 |
| | The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function | Q36031499 |
| | Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer's disease | Q36061394 |
| | CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field | Q36461179 |
| | Apolipoprotein E structure: insights into function. | Q36527194 |
| | Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles | Q36546184 |
| | Molecular mechanisms responsible for the differential effects of apoE3 and apoE4 on plasma lipoprotein-cholesterol levels. | Q36865222 |
| | Understanding the association of apolipoprotein E4 with Alzheimer disease: clues from its structure | Q37307244 |
| | Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism | Q38833309 |
| | Comparison of the stabilities and unfolding pathways of human apolipoprotein E isoforms by differential scanning calorimetry and circular dichroism. | Q39123623 |
| | Studying the role of ApoE in Alzheimer's disease pathogenesis using a systems biology model | Q39331556 |
| | Apolipoprotein E: structure-function relationships | Q40737965 |
| | Human apolipoprotein E: the Alzheimer's disease connection. | Q41239700 |
| | Perspective: Markov models for long-timescale biomolecular dynamics | Q41774653 |
| | Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4. | Q42173611 |
| | Helical structure, stability, and dynamics in human apolipoprotein E3 and E4 by hydrogen exchange and mass spectrometry. | Q42323951 |
| | A unified scheme for initiation and conformational adaptation of human apolipoprotein E N-terminal domain upon lipoprotein binding and for receptor binding activity | Q42615768 |
| | Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. | Q43138847 |
| | Markov models of molecular kinetics: generation and validation | Q43633887 |
| | Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease. | Q44189963 |
| | Identification of slow molecular order parameters for Markov model construction | Q44985905 |
| | Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain | Q46175909 |
| | Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils | Q46212443 |
| | Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains | Q46421943 |
| | Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains. | Q46620615 |
| | Apolipoprotein E*dipalmitoylphosphatidylcholine particles are ellipsoidal in solution | Q46629889 |
| | Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins | Q46656933 |
| | Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. | Q46740358 |
| | Model of biologically active apolipoprotein E bound to dipalmitoylphosphatidylcholine | Q46797037 |
| | FESetup: Automating Setup for Alchemical Free Energy Simulations. | Q50778448 |
| | A monomeric, biologically active, full-length human apolipoprotein E. | Q50928824 |
| | HELANAL: a program to characterize helix geometry in proteins. | Q52079005 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 13 | |
| P304 | page(s) | 2682-2694 | |
| P577 | publication date | 2017-12-01 | |
| P1433 | published in | Biophysical Journal | Q2032955 |
| P1476 | title | Atomistic Insights into Structural Differences between E3 and E4 Isoforms of Apolipoprotein E | |
| P478 | volume | 113 | |